Vanda Pharmaceuticals Provides Update on VQW-765 Clinical Development Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq slides to near one-month low as AI rout deepens
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent oil slips as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 4.28 +0.06 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.22 | 52 Week High | $18.00 | |||
| Open | $4.04 | 52 Week Low | $6.91 | |||
| Day High | $4.30 | P/E | N/A | |||
| Day Low | $4.01 | EPS | $-0.67 | |||
| Volume | 324,209 | |||||
